These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7770417)

  • 1. [Does the diuretic effect of calcium inhibitors play an important role in the hypertensive efficacy?].
    Maldonado Martin A; Gil Extremera B; Rubio Luengo MA
    Presse Med; 1995 Apr; 24(14):686-90. PubMed ID: 7770417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of calcium entry blockers on renin-angiotensin-aldosterone system, renal function and hemodynamics, salt and water excretion and body fluid composition.
    Bauer JH; Sunderrajan S; Reams G
    Am J Cardiol; 1985 Dec; 56(16):62H-67H. PubMed ID: 2933950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies in antihypertensive therapy: implications of the kidney.
    Hollenberg NK
    Am J Med; 1986 Dec; 81(6A):15-9. PubMed ID: 2879443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of calcium antagonists on electrolytes and water balance in hypertensive patients.
    Leonetti G
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S25-9. PubMed ID: 7603074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic effect of calcium antagonists.
    Zanchetti A; Leonetti G
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S33-7. PubMed ID: 2412009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium antagonists and the kidney.
    Chellingsworth M; Kendall MJ
    J Hum Hypertens; 1987 Jun; 1(1):3-8. PubMed ID: 3334055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal actions of calcium antagonists.
    Sterzel RB
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S17-22. PubMed ID: 2455125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term effects of calcium entry blockers on the kidney.
    Bauer JH; Reams G
    Am J Cardiol; 1987 Jan; 59(2):66A-71A. PubMed ID: 3544786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Place of calcium antagonists in the treatment of hypertension.
    Kiowski W
    Cor Vasa; 1990; 32(2 Suppl 1):2-11. PubMed ID: 2200638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonists and renal failure progression.
    Robles NR
    Ren Fail; 2008; 30(3):247-55. PubMed ID: 18350443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonists in hypertension.
    Bühler FR; Kiowski W
    J Hypertens Suppl; 1987 Aug; 5(3):S3-10. PubMed ID: 3312526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal actions of calcium channel antagonists.
    Osswald H; Weinheimer G; Kapp JF
    J Neural Transm Suppl; 1990; 31():39-53. PubMed ID: 2074437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological basis for use of calcium antagonists in hypertension.
    Scriabine A; Kazda S
    Magnesium; 1989; 8(5-6):253-65. PubMed ID: 2693846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New therapeutic approaches to arterial hypertension].
    Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1982 Sep; 112(39):1330-4. PubMed ID: 6755692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of action of calcium antagonists in hypertension.
    Kiowski W; Bolli P; Erne P; Hulthén UL; Bühler FR
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S23-8. PubMed ID: 2455134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat.
    Yagil Y; Miyamoto M; Frasier L; Oizumi K; Koike H
    Am J Hypertens; 1994 Jul; 7(7 Pt 1):637-46. PubMed ID: 7946166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal arteriolar injury by salt intake contributes to salt memory for the development of hypertension.
    Oguchi H; Sasamura H; Shinoda K; Morita S; Kono H; Nakagawa K; Ishiguro K; Hayashi K; Nakamura M; Azegami T; Oya M; Itoh H
    Hypertension; 2014 Oct; 64(4):784-91. PubMed ID: 24980670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.